STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
YTEN YIELD10 BIOSCIENCE INCORPORATED StockScouter® Report
4
StockScouter® Score
YIELD10 BIOSCIENCE INCORPORATED, a micro cap growth company in the healthcare sector, is expected to slightly underperform the market over the next six months with slightly higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
- Short-term relative price momentum exhibits meaningful strength. Postive
Concerns
- The enterprise value-to-sales ratio is much higher than the average for comparably-sized companies in the StockScouter universe. Very Negative
- The multi-period measure of relative price change and consistency is average. Neutral
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be in favor, growth stocks will be in favor, and healthcare stocks will be in favor.
Expected Risk/Return
Core Model Grades
B
N/A
F
C